He may also recommend additional tests, such as blood work, to ensure your overall health is optimized for Semaglutide treatment
However, biopsy results may be equivocal and therefore have the potential to make the differential diagnosis challenging
Ganieva U, Nakamura T, Osuka S, Bayasula, Nakanishi N, Kasahara Y, et al
Beyond weight loss, the SELECT trial showed semaglutide reduces major adverse cardiovascular events by 20 percent in patients with obesity and established cardiovascular disease, even without diabetes [Lincoff SELECT, NEJM 2023]
Every sip leaves you with something worth smiling about
Secondly, given the potential of drugs to modulate cardiac metabolism, the development of new drugs to precisely target specific metabolic pathways will be an important research topic